|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$74,528
|
$14,906
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
Web-based Physical Activity Intervention for Children with ALL
|
5R01CA193478-03
|
$826,706
|
$826,706
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
$379,294
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$1,218
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$188,054
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S1
|
$113,625
|
$2,273
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S2
|
$60,000
|
$1,200
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S3
|
$250,001
|
$5,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S4
|
$200,000
|
$4,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S5
|
$125,000
|
$2,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S6
|
$300,000
|
$6,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S7
|
$241,885
|
$4,838
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S8
|
$293,284
|
$5,866
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-14
|
$2,246,011
|
$44,920
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
$31,478
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
$10,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S3
|
$125,000
|
$6,250
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
$113,311
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S3
|
$223,326
|
$44,665
|
SCHULICK, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
|
|
University of Colorado Cancer Center Support Grant
|
5P30CA046934-30
|
$3,853,226
|
$770,645
|
SCHULICK, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S1
|
$39,685
|
$7,937
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S2
|
$243,547
|
$48,709
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Understanding the niche of minimal residual disease leukemia cells
|
2R01CA172896-06
|
$402,563
|
$402,563
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Understanding Ikaros molecular functions for targeted therapies of pre-B ALL
|
1R01CA230618-01
|
$373,355
|
$373,355
|
SCHJERVEN, HILDE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Unbiased identification of spliceosome vulnerabilities across cancer
|
1R01CA226802-01
|
$455,925
|
$455,925
|
SALOMONIS, NATHAN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-09
|
$343,388
|
$343,388
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
$41,721
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
|
5R01CA176624-05
|
$372,463
|
$372,463
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Transporters and hematopoietic toxicity
|
5R01CA194206-03
|
$484,566
|
$484,566
|
SCHUETZ, JOHN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Translational Research in Cancer
|
2P30CA056036-19
|
$2,888,240
|
$57,765
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Research in Cancer
|
3P30CA056036-19S1
|
$224,993
|
$4,500
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translating genomic discoveries to improved outcomes for high risk acute leukemia
|
5R35CA197695-02
|
$1,077,000
|
$1,077,000
|
MULLIGHAN, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Training Physician Scientists in Pediatric Oncology
|
5T32CA009659-23
|
$214,456
|
$107,228
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Therapeutic insights through patient derived leukemia xenografts
|
5R50CA211404-03
|
$172,232
|
$172,232
|
WUNDERLICH, MARK
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
|
5F31CA196231-04
|
$31,044
|
$31,044
|
LIGGETT, LUTHER
|
UNIVERSITY OF COLORADO DENVER
|
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
$190,688
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
The role of the histone chaperone Chaf1b in sustaining the Hoxa9-driven AML differentiation block
|
1K22CA214849-01
|
$191,970
|
$191,970
|
BLANCO, MARIO
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development
|
5R00CA181500-05
|
$248,999
|
$248,999
|
BLACKBURN, JESSICA
|
UNIVERSITY OF KENTUCKY
|
|
|
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
|
5R01CA195732-03
|
$348,844
|
$174,422
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
|
The Role of miR-29b in NK cell Development in Acute Myeloid Leukemia
|
1K22CA218466-01A1
|
$186,840
|
$46,710
|
MUNDY-BOSSE, BETHANY
|
OHIO STATE UNIVERSITY
|
|
|
The role of H3K79 methylation in IDH-mutant leukemia
|
5R01CA201230-04
|
$438,616
|
$438,616
|
BERNT, KATHRIN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
The Role of DLST in Leukemogenesis
|
1R01CA215059-01A1
|
$377,437
|
$188,719
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
The role and mechanism of FTO in leukemogenesis and drug response
|
5R01CA214965-03
|
$444,571
|
$444,571
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
$369,725
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$385,210
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$15,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$12,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$14,770
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$3,503
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults receiving Hematopoietic Cell Transplantation
|
1R01CA225629-01
|
$524,411
|
$262,206
|
ROSENBERG, ABBY
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Total relevant funding to Childhood Leukemia for this search: $87,288,663
|
